A list of all persons who contribute to the sessions of this conference. Please select a letter below to list all persons with the corresponding surname. Select the presentation in the right-hand column to access session and presentation details.
|
Author(s) | Organization(s) | Session |
Ha, Tae Youl | Korea Food Research Institute, Korea, Republic of (South Korea) | Tea Break and poster session Tea Break and poster session Presenter |
Haack, Tobias B. | Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany, 72076; Center for Rare Diseases, University of Tübingen, Tübingen, Germany, 72076 | Poster session |
Haapanen, Outi | Department of Physics, University of Helsinki, Finland | Session 2.3: Modelling pathogenic mechanisms: OXPHOS, metabolic rewiring and tissue specificity |
Habermann, Bianca | Institut de Biologie du Développement de Marseille (IBDM), CNRS, UMR7288, Aix-Marseille Université, Marseille, France. | Poster session |
Haferkamp, Undine | Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, ScreeningPort, Hamburg, Germany | Tea Break and poster session |
Hage, Rabih | Centre Hospitalier National d’Ophtalmologie des Quinze Vingts, Paris, France | Session 4.2: Therapy 2: clinical trials Tea Break and poster session |
Haimilahti, Kimmo | Research Program for Stem Cells and Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland | Session 4.2: Therapy 2: clinical trials Presenter Tea Break and poster session |
Haimilahti, Kimmo | STEMM, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland | Tea Break and poster session |
Haimilahti, Kimmo | University of Helsinki, Finland | Tea Break and poster session |
Haimilahti, Kimmo | Research Program for Stem Cells and Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland | Tea Break and poster session Presenter |
Hakkarainen, Antti | HUS Diagnostic Center, Radiology, Helsinki University and Helsinki University Hospital, Helsinki, Finland | Session 4.2: Therapy 2: clinical trials Tea Break and poster session |
Haller, Ronald G | University of Texas Southwestern Medical Center, United States of America | Poster session |
Hämäläinen, Riikka Helena | University of Eastern Finland, Finland | Tea Break and poster session |
Hamers, Ilse H.J. | Department of Toxicogenomics, Maastricht University, Maastricht, The Netherlands | Poster session |
Han, Alexander | Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore 138673, Singapore | Session 5.1: Late breaking news session |
Han, Jinming | Applied Immunology and Immunotherapy, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska University Hospital, Stockholm 17176, Sweden | Tea Break and poster session |
Handler, Alyssa | Stealth BioTherapeutics, Needham, MA, United States of America | Tea Break and poster session |
Hangas, Anu | University of Eastern Finland, Finland | Tea Break and poster session Tea Break and poster session Presenter Tea Break and poster session |
Hanna, Michael | Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom | Session 2.2: Clinical 1: from new genes to old and novel phenotypes Tea Break and poster session |
Hanna, Michael G | Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK | Poster session Session 3.4: Clinical 2: natural history, biomarkers and outcome measures |
Hanna, Michael G. | Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK | Session 2.2: Clinical 1: from new genes to old and novel phenotypes Session 2.2: Clinical 1: from new genes to old and novel phenotypes |
Hanna, Michael G. | Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK | Session 3.4: Clinical 2: natural history, biomarkers and outcome measures |
Hanna, Michael G. | Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK | Tea Break and poster session |
Hanna, Michael G. | Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK | Tea Break and poster session |
Hanna, Michael G. | UCL Queen Square Institute of Neurology, United Kingdom; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK.; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK | Tea Break and poster session Tea Break and poster session |
Hanna, Michael G. | Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK | Tea Break and poster session |
Hansen, Fynn | Max-Planck Institute of Biochemistry, Martinsried, Germany | Tea Break and poster session |
Hansen, Jakob | Department of Forensic Medicine, Aarhus University, Aarhus, Denmark | Poster session |
Hansikova, Hana | Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic | Poster session Presenter Poster session |
Hansikova, Hana | First Faculty of Medicine, Charles University; and General University Hospital in Prague | Poster session |
Hansíková, Hana | Department of Paediatrics and Inherited Metabolic Disorders, Charles University and General University Hospital in Prague, Prague, Czech Republic | Poster session |
Hansikova, Hana | Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague | Poster session |
Hansíková, Hana | 1st Faculty of medicine, Charles University, Prague, Czech Republic | Tea Break and poster session |
Hanssen, Eric | Ian Holmes Imaging Centre, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Victoria, Australia | Poster session |
Hansson, Magnus J. | Mitochondrial Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden; Abliva AB, Lund, Sweden | Tea Break and poster session |
Hansson, Magnus J. | Lund University, Sweden | Tea Break and poster session |
Harashima, Hideyoshi | Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan | Tea Break and poster session Tea Break and poster session Tea Break and poster session |
Harashima, Hideyoshi | Faculty of Engineering, Hokkaido University, Sapporo, Japan | Tea Break and poster session |
Hardij, Rianne | Department of Toxicogenomics, Maastricht University, Maastricht, The Netherlands | Poster session |
Hardy, Gaelle | Laboratoire de génétique moléculaire: maladies héréditaires et oncologie, Service de biochimie, biologie moléculaire et toxicologie environnementale, CHU Grenoble et des Alpes, Institut de biologie et pathologie, Grenoble | Tea Break and poster session |
Hardy, Steven A | National Disease Registration Service, NHS Digital, Leeds, UK | Session 3.4: Clinical 2: natural history, biomarkers and outcome measures |
Harjuhaahto, Sandra | Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki | Tea Break and poster session Presenter |
Harley, Jasmine | Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore 138673, Singapore | Session 5.1: Late breaking news session Presenter |
Harrison, Emma | Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom (add-tr.mitoteam@nhs.net) | Tea Break and poster session |
Hartono, Stella R | Department of Molecular and Cellular Biology, University of Califofnia, Davis | Tea Break and poster session |
Hartopp, Naomi | University of Sheffield, Sheffield Institute for Translational Neuroscience, United Kingdom | Poster session Presenter Tea Break and poster session |
Hasselholt, Stine | Department of Clinical Medicine, Aarhus University, Denmark; Center of Functionally Integrative Neuroscience | Tea Break and poster session Presenter |
Hata, Ryuji | Fujita Health University School of Medicine, Japan | Tea Break and poster session |
Hathazi, Denisa | Department of Clinical Neurosciences, University of Cambridge, United Kingdom | Poster session Session 3.2: Mitochondrial mechanisms in neurodegeneration and neurodevelopment Presenter |
Hattersley, Andrew T. | Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK | Tea Break and poster session |
Hattersly, Andrew T | Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK | Poster session |
Hazan, Reut | Hebrew university, Israel | Tea Break and poster session Presenter |
Heales, Simon | Neurometabolic Unit, NHNN, University College London Hospitals; Chemical Pathology Laboratory, Great Ormond Street Hospital for Children; Great Ormond Street Institute of Child Health, University College London | Tea Break and poster session |
Heales, Simon J. R. | Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK; Neurometabolic Unit, The National Hospital for Neurology and Neurosurgery, London, UK | Session 2.2: Clinical 1: from new genes to old and novel phenotypes |
Heid, Iris | University of Regensburg, Germany | Poster session |
Heidler, Julian | Institute for Cardiovascular Physiology, Goethe University Frankfurt, Germany | Poster session |
Heidler, Juliana | Functional Proteomics Group, Institute for Cardiovascular Physiology, Goethe University Frankfurt, 60590, Frankfurt am Main, Germany | Poster session |
Heiduschka, Sonja | Department of General Pediatrics, Neonatology and Pediatric Cardiology, Heinrich Heine Universi-ty, Düsseldorf, Germany | Tea Break and poster session |
Heiman, Myriam | Picower Institute for Learning and Memory, MIT, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, MIT, Cambridge, MA, USA | Session 5.1: Late breaking news session |
Heinrichs, Marleen | Department of Cellular Biochemistry, University Medical Center Goettingen, Goettingen, Germany; Cluster of Excellence “Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells” (MBExC), University of Goettingen, Goettingen, Germany | Tea Break and poster session Presenter |
Heluani Gahete, Hayat | Andalusian Centre for Developmental Biology (CABD). CSIC-Universidad Pablo de Olavide-Junta de Andalucía. Carretera de Utrera Km 1, 41013 Sevilla, Spain.; Department of Molecular Biology and Biochemical Engineering, Universidad Pablo de Olavide. Carretera de Utrera Km 1, 41013 Seville, Spain | Session 3.3: Metabolic stress responses in mitochondrial diseases and cancer |
Hemel, Irene M.G.M. | Maastricht Centre for Systems Biology (MaCSBio), Maastricht University, The Netherlands | Tea Break and poster session Presenter |
Hempel, Maja | Institute of Human Genetics, University Medical Center Eppendorf, Hamburg, Germany; Current address: Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany | Session 2.2: Clinical 1: from new genes to old and novel phenotypes |
Hempfling, Stefan | Institute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany; Bavarian NMR Centre, Department of Bioscience, School of Natural Sciences, Technical University of Munich, 85747 Garching, Germany | Session 5.1: Late breaking news session Tea Break and poster session |
Henckel, Melissa M | University of Colorado/Rocky Mountain Regional VA Medical Center, United States of America | Poster session |
Hendriks, Sacha | Department of Genetics, Translational Metabolic Laboratory, Radboudumc, Nijmegen, The Netherlands. | Tea Break and poster session |
Henke, Marie-Thérèse | Charité-Universitätsmedizin Berlin, Department of Neuropediatrics, Berlin, Germany | Poster session Tea Break and poster session Presenter |
Hennick, Adèle | Institut NeuroMyoGene, PGNM UMR5261, INSERM U1315, Université Claude Bernard Lyon I Faculté de médecine Rockefeller, Lyon 08 France | Poster session |
Henrion, Daniel | UMR CNRS 6015, INSERM U1083, MitoVasc Institute, CarMe Team, University of Angers, France | Tea Break and poster session |
Hentschel, Andreas | Leibniz Institute of Analytical Sciences, ISAS, Dortmund, Germany | Session 5.1: Late breaking news session Tea Break and poster session |
Hentschel, Julia | Institute of Human Genetics, University Hospital, Leipzig, Germany | Poster session |
Herbert, Mary | Newcastle University, United Kingdom; Newcastle Fertility Centre | Session 4.3: Therapy 3: reproductive options and mtDNA editing Presenter Tea Break and poster session |
Hernández, Ana Sandra | Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain; BCNatal—Barcelona Centre for Maternal-Foetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), IDIBAPS, University of Barcelona, 08036 Barcelona, Spain | Tea Break and poster session |
Hernández-Camacho, Juan Diego | Institut Pasteur, Mitochondrial Biology Group, CNRS UMR 3691, Université Paris Cité, Paris, France. | Poster session Presenter |
Herrero Martín, Juan Cruz | Department of Molecular Biology, Centro de Biología Molecular "Severo Ochoa" (CBMSO-UAM-CSIC), Madrid, Spain | Poster session |
Herrero-Martínez, Diego | Programa de Terapia Génica y Regulación de la Expresión Génica, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra - Pamplona (Spain); Instituto de Investigación Sanitaria de Navarra, IdiSNA - Pamplona (Spain) | Tea Break and poster session |
Hesp, Laura FB | Radboud University Medical Center, The Netherlands | Poster session Session 3.2: Mitochondrial mechanisms in neurodegeneration and neurodevelopment |
Heyne, Estelle | Department of Cardiothoracic Surgery, University Hospital of Friedrich-Schiller-University Jena, Germany | Poster session |
Heyne, Estelle | Jena University Hospital, Friedrich-Schiller University of Jena, Germany | Tea Break and poster session Tea Break and poster session Presenter |
Hibino, Mitsue | Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan; Faculty of Engineering, Hokkaido University, Sapporo, Japan | Tea Break and poster session Tea Break and poster session Presenter Tea Break and poster session Tea Break and poster session |
Hidalgo, Juan Manuel | Universitat Autònoma de Barcelona, Institut de Neurociències, Bellaterra, Spain | Tea Break and poster session |
Hidalgo Gutiérrez, Agustín | Physiology Department, Biomedical Research Center, University of Granada, Granada, Spain | Tea Break and poster session |
Hidalgo-Gutierrez, Agustin | Department of Neurology, Columbia University Irving Medical Center, New York, NY, 10032, United States | Poster session Poster session Session 2.2: Clinical 1: from new genes to old and novel phenotypes Presenter |
Hidalgo-Gutierrez, Agustin | Columbia University Irving Medical Center, New York, USA, United States of America | Session 4.2: Therapy 2: clinical trials |
Hidalgo-Gutiérrez, Agustín | Physiology Department, Biomedical Research Center, University of Granada, Spain | Tea Break and poster session |
Hidalgo-Gutierrez, Agustin | Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA | Tea Break and poster session Presenter |
Hietakangas, Ville | Helsinki Institute of Life Science HiLIFE, University of Helsinki; Faculty of Biological and Environmental Sciences, University of Helsinki | Tea Break and poster session |
Higgins-Chen, Albert | Yale University, United States of America | Poster session |
Hikage, Yuga | National Defense Academy, Japan | Poster session |
Hikmat, Omar | Department of Paediatrics and Adolescent Medicine, Haukeland University Hospital, Norway; Department of Clinical Medicine (K1), University of Bergen, Norway; Department of Pediatrics, Haukeland University Hospital, Norway | Session 3.4: Clinical 2: natural history, biomarkers and outcome measures Presenter Tea Break and poster session Tea Break and poster session |
Hilander, Taru | Genetics Section, Molecular and Clinical Sciences, St George’s, University of London, London, United Kingdom | Tea Break and poster session |
Hillen, Hauke | Department of Cellular Biochemistry, University Medical Center Göttingen, Germany; Research Group Structure and Function of Molecular Machines, Max-Planck-Institute for Multidisciplinary Sciences Göttingen, Germany; Cluster of Excellence “Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells” (MBExC), University of Goettingen, Goettingen, Germany; Cluster of Excellence (MBExC), University of Göttingen, Germany | Session 2.4: New technological developments and OMICS Presenter Tea Break and poster session Tea Break and poster session |
Hiltunen, J Kalervo | Faculty of Biochemistry and Molecular Medicine, University of Oulu, Finland | Tea Break and poster session |
Hiltunen, J. Kalervo | Faculty of Biochemistry and Molecular Medicine, University of Oulu, Finland | Poster session |
Hines, Declan | Department of Clinical Neurosciences, University of Cambridge, United Kingdom | Tea Break and poster session |
Hink, Mark A | University of Amsterdam, The Netherlands | Poster session Session 3.2: Mitochondrial mechanisms in neurodegeneration and neurodevelopment |
Hirano, M. | H. Houston Merritt Neuromuscular Research Center, Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA | Tea Break and poster session |
Hirano, Michio | Columbia University Irving Medical Center, United States of America | Poster session |
Hirano, Michio | Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA | Session 2.2: Clinical 1: from new genes to old and novel phenotypes |
Hirano, Michio | Columbia University Irving Medical Center, United States of America | Session 3.4: Clinical 2: natural history, biomarkers and outcome measures Session 4.2: Therapy 2: clinical trials Presenter |
Hirano, Michio | Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA | Tea Break and poster session |
Hirano, Michio | Columbia University Irving Medical Center, United States of America | Tea Break and poster session |
Hiz, Semra | Izmir Biomedicine and Genome Center, Dokuz Eylul University Health Campus, Izmir, Turkey | Session 2.2: Clinical 1: from new genes to old and novel phenotypes |
Hnízda, Aleš | Department of Paediatrics and Inherited Metabolic Disorders, Charles University and General University Hospital in Prague, Prague, Czech Republic | Poster session |
Ho, Lena | Duke-NUS Medical School, Singapore | Poster session Presenter Session 2.3: Modelling pathogenic mechanisms: OXPHOS, metabolic rewiring and tissue specificity Presenter |
Hoberg, Emily | Department of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, SE-405 30 Gothenburg, Sweden | Tea Break and poster session |
Hock, Daniella | Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia. | Poster session |
Hock, Daniella | Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, Australia | Tea Break and poster session |
Hock, Daniella | University of Melbourne, Parkville, Australia | Tea Break and poster session |
Hock, Daniella | University of Melbourne, Melbourne, Australia | Tea Break and poster session |
Hock, Daniella H | University of Melbourne, Parkville, Australia | Tea Break and poster session Presenter |
Hodgkinson, Alan | Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, King’s College London, London, United Kingdom | Poster session Presenter |
Hodsdon, Philip | Oxford Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; NHS Highly Specialised Services for Rare Mitochondrial Disorders, Oxford University Hospitals NHS Foundation Trust, Oxford, UK | Tea Break and poster session Tea Break and poster session |
Hoeijmakers, Janneke G.J. | School for Mental Health and Neurosciences (MHeNS), Maastricht University Medical Centre+, Maastricht, The Netherlands; Department of Neurology, Maastricht University Medical Centre+, Maastricht, The Netherlands | Session 4.2: Therapy 2: clinical trials |
Hohorst, Lisa | CECAD, Germany | Tea Break and poster session |
Hoitzing, Hanne | Department of Mathematics, Imperial College London, United Kingdom | Tea Break and poster session |
Holm, Christian | Department of Biomedicine, Aarhus Research Center for Innate Immunology, Aarhus University, Aarhus, Denmark | Session 3.1: Inflammation and Immunity as mitochondrial contributor to pathology Tea Break and poster session |
Holmes, Holly E. | Elysium Health New York, New York, NY 10013, USA | Tea Break and poster session |
Honzik, Tomas | Department of Pediatrics and Inherited Metabolic Disorders, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic | Poster session Poster session |
Honzík, Tomáš | 1st Faculty of medicine, Charles University, Prague, Czech Republic | Tea Break and poster session |
Hool, Livia | School of Human Sciences (Physiology), The University of Western Australia, Crawley, Western Australia 6009, Australia.; Victor Chang Cardiac Research Institute, Darlinghurst, Sydney, New South Wales 2010, Australia. | Tea Break and poster session |
Hopton, Sila | Wellcome Centre for Mitochondrial Research, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE1 4LP, UK | Session 2.1: mtDNA maintenance and expression Tea Break and poster session |
Horton, Rachel L. | Centre for Personalised Medicine, and Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK; Clinical Ethics, Law and Society, Faculty of Medicine, University of Southampton, Southampton, UK | Tea Break and poster session |
Horvath, Rita | Department of Clinical Neurosciences, University of Cambridge, United Kingdom | Poster session |
Horvath, Rita | Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge, UK. | Poster session Session 2.2: Clinical 1: from new genes to old and novel phenotypes |
Horvath, Rita | Cambridge-UK, United Kingdom | Session 2.2: Clinical 1: from new genes to old and novel phenotypes Presenter Session 3.2: Mitochondrial mechanisms in neurodegeneration and neurodevelopment |
Horvath, Rita | Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK | Session 3.4: Clinical 2: natural history, biomarkers and outcome measures Session 3.4: Clinical 2: natural history, biomarkers and outcome measures |
Horvath, Rita | Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom (add-tr.mitoteam@nhs.net) | Tea Break and poster session Tea Break and poster session |
Horvath, Steve | Altos labs, United States of America | Poster session |
Houghton, David | National Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre (BRC), Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, UK | Session 3.4: Clinical 2: natural history, biomarkers and outcome measures |
Houghton, David | Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute; NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne NE2 4HH, UK | Tea Break and poster session |
Houghton, David | National Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre (BRC), Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, UK | Tea Break and poster session |
Houlden, Henry | Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK | Session 2.2: Clinical 1: from new genes to old and novel phenotypes Session 2.2: Clinical 1: from new genes to old and novel phenotypes |
Houštěk, Josef | Institute of Physiology of the Czech Academy of Sciences, Czech Republic | Poster session |
Houštěk, Josef | Department of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic | Poster session |
Houštěk, Josef | Institute of Physiology of the Czech Acad. Sci., Prague, Czech Republic | Poster session |
Houštěk, Josef | Laboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic | Poster session Tea Break and poster session Tea Break and poster session |
Houtkooper, Riekelt | Laboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands | Session 3.1: Inflammation and Immunity as mitochondrial contributor to pathology Tea Break and poster session |
Howting, Denise | Harry Perkins Institute of Medical Research, Perth, Australia | Tea Break and poster session |
Høyer, Helle | Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway | Tea Break and poster session |
Hrabě de Angelis, Martin | Institute of Experimental Genetics, German Mouse Clinic, Helmholtz Center Munich, German Research Center for Environmental Health, Germany; Member of German Center for Diabetes Research (DZD), Germany; Chair of Experimental Genetics Experimental Genetics, School of Life Science Weihenstephan, Technische Universität München, Germany; Contributed equally | Tea Break and poster session |
Hsieh, Yu-Hsin | Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), 10115 Berlin, Germany | Session 2.4: New technological developments and OMICS |
Hu, Bowen | Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki | Tea Break and poster session |
Huang, Cheng-Kai | Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany | Tea Break and poster session |
Huang, Sidong | McGill University, Canada | Tea Break and poster session |
Huang, Yu-Wen | Mackay Memorial Hospital, Taiwan | Tea Break and poster session Presenter |
Huber, Nicole | Medical University of Innsbruck, 6020 Innsbruck, Austria | Session 1.1: The impact of mtDNA variation and environment on rare and common diseases |
Hudson, Gavin | University of Newcastle, Newcastle upon Tyne, UK | Poster session |
Hudson, Gavin H. | Wellcome Centre for Mitochondrial Research and Institute for Translational and Clinical Research, Newcastle University, Newcastle upon Tyne, UK | Tea Break and poster session |
Hughes, Laetitia | Harry Perkins Institute of Medical Research, Nedlands, Western Australia 6009, Australia; ARC Centre of Excellence in Synthetic Biology, QEII Medical Centre, Nedlands, Western Australia 6009, Australia; Centre for Medical Research, The University of Western Australia, QEII Medical Centre, Nedlands, Western Australia 6009, Australia. | Tea Break and poster session |
Hughes, Rachel | University of Sheffield, Sheffield Institute for Translational Neuroscience, United Kingdom | Poster session |
Hughes, Rachel M | Sheffield Institute for Translational Neuroscience, University of Sheffield, United Kingdom | Tea Break and poster session Presenter |
Human, Ronel | Department of Paediatrics, Steve Biko Academic Hospital, University of Pretoria, Pretoria, South Africa | Session 2.2: Clinical 1: from new genes to old and novel phenotypes Tea Break and poster session |
Hunter, Heather | The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK | Session 3.4: Clinical 2: natural history, biomarkers and outcome measures Tea Break and poster session Tea Break and poster session |
Hunter, Matthew | Monash Genetics, Monash Health, Melbourne, Australia; Department of Paediatrics, Monash University, Melbourne, Australia | Tea Break and poster session |
Hurd, Thomas R | Department of Molecular Genetics, University of Toronto, Toronto, Canada | Tea Break and poster session |
Hyslop, Louise | Newcastle Fertility Centre | Session 4.3: Therapy 3: reproductive options and mtDNA editing |